JP2022544031A5 - - Google Patents
Info
- Publication number
- JP2022544031A5 JP2022544031A5 JP2022505359A JP2022505359A JP2022544031A5 JP 2022544031 A5 JP2022544031 A5 JP 2022544031A5 JP 2022505359 A JP2022505359 A JP 2022505359A JP 2022505359 A JP2022505359 A JP 2022505359A JP 2022544031 A5 JP2022544031 A5 JP 2022544031A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- cycloalkyl
- optionally substituted
- ch2cf3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019902641A AU2019902641A0 (en) | 2019-07-25 | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof | |
| AU2019902641 | 2019-07-25 | ||
| PCT/AU2020/050759 WO2021012014A1 (en) | 2019-07-25 | 2020-07-24 | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544031A JP2022544031A (ja) | 2022-10-17 |
| JP2022544031A5 true JP2022544031A5 (enExample) | 2023-07-28 |
Family
ID=74192415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505359A Pending JP2022544031A (ja) | 2019-07-25 | 2020-07-24 | リシルオキシダーゼのジフルオロハロアリルアミンスルホン誘導体阻害剤、調製方法、及びそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220251036A1 (enExample) |
| EP (1) | EP4003952A4 (enExample) |
| JP (1) | JP2022544031A (enExample) |
| KR (1) | KR20220040480A (enExample) |
| CN (1) | CN114286816B (enExample) |
| AU (1) | AU2020317374A1 (enExample) |
| BR (1) | BR112022000782A2 (enExample) |
| CA (1) | CA3145738A1 (enExample) |
| MX (1) | MX2022001031A (enExample) |
| TW (1) | TW202114991A (enExample) |
| WO (1) | WO2021012014A1 (enExample) |
| ZA (1) | ZA202202376B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4173639A4 (en) | 2020-06-26 | 2024-03-13 | RaQualia Pharma Inc. | METHOD FOR SELECTING A CANCER PATIENT FOR WHICH COMBINATION THERAPY OF A RETINOID AND A CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND COMBINATION DRUG OF A RETINOID AND A CANCER TREATMENT AGENT |
| CN113440477B (zh) * | 2021-08-12 | 2022-10-11 | 海南海神同洲制药有限公司 | 一种低粘度酮康唑乳膏及其制备方法 |
| US12233056B2 (en) | 2022-04-06 | 2025-02-25 | Syntara Limited | Lysyl oxidase inhibitors for treating myeloid malignancies |
| GB202209624D0 (en) | 2022-06-30 | 2022-08-17 | Institute Of Cancer Res Royal Cancer Hospital | Prodrugs |
| GB202209622D0 (en) | 2022-06-30 | 2022-08-17 | Institute Of Cancer Res Royal Cancer Hospital | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8426587B2 (en) * | 2007-11-21 | 2013-04-23 | Pharmaxis Ltd. | Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor |
| CA2871793C (en) * | 2012-05-02 | 2020-09-15 | Pharmaxis Ltd. | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
| MX376835B (es) * | 2015-03-06 | 2025-03-07 | Pharmakea Inc | Inhibidores de lisil oxidasa tipo 2 fluorinados y usos de los mismos. |
| AU2017218889A1 (en) * | 2016-02-09 | 2018-08-30 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
| SG11201806700RA (en) * | 2016-02-12 | 2018-09-27 | Pharmaxis Ltd | Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof |
| CN110709385A (zh) * | 2017-03-02 | 2020-01-17 | 法玛西斯有限公司 | 赖氨酰氧化酶的卤代烯丙胺吡唑衍生物抑制剂及其用途 |
| GB201716871D0 (en) * | 2017-10-13 | 2017-11-29 | Inst Of Cancer Research: Royal Cancer Hospital | Compounds |
| AR115906A1 (es) * | 2018-08-03 | 2021-03-10 | Pharmaxis Ltd | Derivados de haloalilamina sulfona como inhibidores de lisil oxidasas |
-
2020
- 2020-07-24 MX MX2022001031A patent/MX2022001031A/es unknown
- 2020-07-24 AU AU2020317374A patent/AU2020317374A1/en not_active Abandoned
- 2020-07-24 CA CA3145738A patent/CA3145738A1/en active Pending
- 2020-07-24 CN CN202080060323.3A patent/CN114286816B/zh not_active Expired - Fee Related
- 2020-07-24 KR KR1020227006461A patent/KR20220040480A/ko not_active Withdrawn
- 2020-07-24 TW TW109125162A patent/TW202114991A/zh unknown
- 2020-07-24 JP JP2022505359A patent/JP2022544031A/ja active Pending
- 2020-07-24 EP EP20844719.3A patent/EP4003952A4/en not_active Withdrawn
- 2020-07-24 US US17/629,543 patent/US20220251036A1/en not_active Abandoned
- 2020-07-24 BR BR112022000782A patent/BR112022000782A2/pt not_active Application Discontinuation
- 2020-07-24 WO PCT/AU2020/050759 patent/WO2021012014A1/en not_active Ceased
-
2022
- 2022-02-24 ZA ZA2022/02376A patent/ZA202202376B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3661560B1 (en) | Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors | |
| US11591311B2 (en) | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides | |
| WO2018122168A1 (en) | Combinations of bub1 kinase and parp inhibitors | |
| CN107810176B (zh) | 作为mIDH1抑制剂的N-薄荷基苯并咪唑类化合物 | |
| US10179123B2 (en) | 2-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors | |
| JP2017520607A5 (enExample) | ||
| JP2022537358A5 (enExample) | ||
| EP3411497A1 (en) | Copanlisib biomarkers | |
| CN107848985A (zh) | 制备取代的3‑(2‑苯胺基‑1‑环己基‑1h‑苯并咪唑‑5‑基)丙酸衍生物的方法 | |
| WO2017134030A1 (en) | Copanlisib biomarkers | |
| US20220251036A1 (en) | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof | |
| JP2018522049A5 (enExample) | ||
| JP7280286B2 (ja) | びまん性大細胞型ｂ細胞リンパ腫を治療するための５－フルオロ－４－（４－フルオロ－２－メトキシフェニル）－ｎ－｛４－［（ｓ－メチルスルホンイミドイル）メチル］ピリジン－２－イル｝ピリジン－２－アミンの使用 | |
| WO2018215282A1 (en) | Combination of bub1 and pi3k inhibitors | |
| RU2491934C2 (ru) | Лечение фиброзирующих нарушений | |
| WO2018158175A1 (en) | Combination of bub1 inhibitors | |
| WO2019002068A1 (en) | COMBINATION OF A PI3K INHIBITOR AND AN ANDROGEN RECEPTOR ANTAGONIST | |
| JP2024505252A (ja) | Ｐｔｅｎ不活性化突然変異を有する患者における癌の治療 | |
| EP3585437B1 (en) | Combinations of copanlisib with anti-pd-1 antibody | |
| EP4581011A1 (en) | Novel selective inhibitors of lysyl oxidases | |
| JP2018509439A (ja) | 多発性骨髄腫を治療するための４−（４−フルオロ−２−メトキシフェニル）−ｎ−｛３−［（ｓ−メチルスルホンイミドイル）メチル］フェニル｝−１，３，５−トリアジン−２−アミンの使用 | |
| WO2021260443A1 (en) | Combinations of 2,3-dihydroimidazo[1,2-c]quinazolines |